Clearside Biomedical, Inc. - stock earnings
CLSD Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -4.8 million USD | 6.3 million USD |
| 2023Q3 | -9.3 million USD | 859000 USD |
| 2023Q2 | -9.1 million USD | 1.0 million USD |
| 2023Q1 | -13.1 million USD | 4000 USD |
| 2022Q4 | -8.6 million USD | 330000 USD |
| 2022Q3 | -8.9 million USD | 266000 USD |
| 2022Q2 | -7.8 million USD | 384000 USD |
| 2022Q1 | -7.6 million USD | 347000 USD |
| 2021Q4 | 18.7 million USD | 25.7 million USD |
| 2021Q3 | -4.9 million USD | 3.1 million USD |
| 2021Q2 | -6.1 million USD | 780000 USD |
| 2021Q1 | -7.4 million USD | 34000 USD |
| 2020Q4 | -7.1 million USD | 11000 USD |
| 2020Q3 | -2.4 million USD | 3.4 million USD |
| 2020Q2 | -5.8 million USD | 354000 USD |
| 2020Q1 | -2.9 million USD | 4.1 million USD |
| 2019Q4 | -3.1 million USD | 1.9 million USD |
| 2019Q3 | -6.5 million USD | 141000 USD |
| 2019Q2 | -5.7 million USD | 45000 USD |
| 2019Q1 | -15.4 million USD | 45000 USD |
| 2018Q4 | -21.6 million USD | 30000 USD |
| 2018Q3 | -23.9 million USD | ? USD |
| 2018Q2 | -20.7 million USD | ? USD |
| 2018Q1 | -16.6 million USD | 55000 USD |
| 2017Q4 | -16.5 million USD | 55000 USD |
| 2017Q3 | -18.3 million USD | 155000 USD |
| 2017Q2 | -13.8 million USD | 130000 USD |
| 2017Q1 | -10.4 million USD | 5000 USD |
| 2016Q4 | -9.7 million USD | 5000 USD |
| 2016Q3 | -5.6 million USD | 5000 USD |
| 2016Q2 | -5.1 million USD | 5000 USD |
| 2016Q1 | -5.4 million USD | 505000 USD |
| 2015Q4 | -5.2 million USD | ? USD |
| 2015Q3 | -3.5 million USD | ? USD |
| 2015Q2 | -5.2 million USD | ? USD |
| 2015Q1 | -3.8 million USD | ? USD |
| 2014Q4 | -2.7 million USD | ? USD |
CLSD Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -32.5 million USD | 8.2 million USD |
| 2022 | -34.1 million USD | 1.3 million USD |
| 2021 | 376000 USD | 29.6 million USD |
| 2020 | -18.0 million USD | 7.9 million USD |
| 2019 | -30.6 million USD | 2.2 million USD |
| 2018 | -82.8 million USD | 30000 USD |
| 2017 | -59.0 million USD | 345000 USD |
| 2016 | -25.9 million USD | 520000 USD |
| 2015 | -17.6 million USD | ? USD |
| 2014 | -10.2 million USD | ? USD |
| 2013 | -7.3 million USD | ? USD |
CLSD
Price: $1.31
52 week price:
Earnings Per Share: -0.53 USD
P/E Ratio: -2.24
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 411200
Ebitda: -18.1 millionMarket Capitalization: 97.9 million